REGABATIN CRX Trademark

Trademark Overview


On Thursday, February 5, 2015, a trademark application was filed for REGABATIN CRX with the United States Patent and Trademark Office. The USPTO has given the REGABATIN CRX trademark a serial number of 86525391. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Friday, October 6, 2017. This trademark is owned by Intellipharmaceutics Corp.. The REGABATIN CRX trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Drug delivery systems, namely, tablets, capsules, and pellets that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations for humans; drug delivery systems, namely, oral solid dose tablets or capsules that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations for humans; pharmaceutical preparations, namely, tablets, capsules, and pellets for humans that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations, all sold as an integral component of pharmaceutical preparations for use in the treatment of attention deficit disorders, central nervous system disorders, depression, diabetes, epilepsy, gastric disorders, gastro-intestinal tract disorders, hypertension, infection, inflammation, pain, rheumatoid arthritis and rhinitis

Research and development services for others in the pharmaceutical sciences, namely, the development and application of drug delivery technologies to the development of controlled, timed release and/or targeted release pharmaceutical preparations
regabatin crx

General Information


Serial Number86525391
Word MarkREGABATIN CRX
Filing DateThursday, February 5, 2015
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateFriday, October 6, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Disclaimer with Predetermined Text"CRX"
Goods and ServicesDrug delivery systems, namely, tablets, capsules, and pellets that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations for humans; drug delivery systems, namely, oral solid dose tablets or capsules that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations for humans; pharmaceutical preparations, namely, tablets, capsules, and pellets for humans that provide controlled timed release and/or targeted release of the active ingredients of pharmaceutical preparations, all sold as an integral component of pharmaceutical preparations for use in the treatment of attention deficit disorders, central nervous system disorders, depression, diabetes, epilepsy, gastric disorders, gastro-intestinal tract disorders, hypertension, infection, inflammation, pain, rheumatoid arthritis and rhinitis
Goods and ServicesResearch and development services for others in the pharmaceutical sciences, namely, the development and application of drug delivery technologies to the development of controlled, timed release and/or targeted release pharmaceutical preparations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 19, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, February 19, 2015
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameIntellipharmaceutics Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressToronto
CA

Trademark Events


Event DateEvent Description
Friday, October 6, 2017ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Friday, October 6, 2017ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, March 10, 2017UNDELIVERABLE MAIL - COURTESY COPY MAILED
Wednesday, March 8, 2017NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Wednesday, March 8, 2017INQUIRY TO SUSPENSION E-MAILED
Wednesday, March 8, 2017SUSPENSION INQUIRY WRITTEN
Wednesday, March 1, 2017LIE CHECKED SUSP - TO ATTY FOR ACTION
Friday, September 9, 2016UNDELIVERABLE MAIL - COURTESY COPY MAILED
Friday, August 26, 2016NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, August 26, 2016LETTER OF SUSPENSION E-MAILED
Friday, August 26, 2016SUSPENSION LETTER WRITTEN
Friday, August 5, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, August 5, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 25, 2016TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, July 25, 2016NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, July 25, 2016INQUIRY TO SUSPENSION E-MAILED
Monday, July 25, 2016SUSPENSION INQUIRY WRITTEN
Thursday, July 21, 2016ASSIGNED TO LIE
Wednesday, January 6, 2016NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, January 6, 2016LETTER OF SUSPENSION E-MAILED
Wednesday, January 6, 2016SUSPENSION LETTER WRITTEN
Tuesday, November 24, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, November 24, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 23, 2015ASSIGNED TO LIE
Wednesday, November 4, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, May 14, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 14, 2015NON-FINAL ACTION E-MAILED
Thursday, May 14, 2015NON-FINAL ACTION WRITTEN
Tuesday, May 12, 2015ASSIGNED TO EXAMINER
Thursday, February 19, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, February 9, 2015NEW APPLICATION ENTERED IN TRAM